Novo Nordisk Gains as Ozempic Found To Lower Dementia Rates
Novo Nordisk rose Friday after the release of an Oxford study that showed the Danish company’s diabetes drug Ozempic was linked to lower rates of dementia and a range of mental problems.
( 20
min )